Disparity in the In Vitro versus In Vivo Regulation of Fibronectin‐Binding Proteins by 2 Global Regulators,saeRSandsigB, inStaphylococcus aureus
Author(s) -
Ambrose L. Cheung,
SooJin Yang,
Arnold S. Bayer,
Yan Q. Xiong
Publication year - 2009
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/606011
Subject(s) - fibronectin , staphylococcus aureus , in vitro , microbiology and biotechnology , in vivo , ex vivo , mutant , biology , chemistry , bacteria , biochemistry , gene , genetics , extracellular matrix
Fibronectin-binding protein A plays an important role in Staphylococcus aureus endovascular infections. We characterized the sigB-saeRS-fnbA expression network with fibronectin binding in vitro and in an experimental infective endocarditis (IE) model using parental strains RN6390 and SH1000 and their respective isogenic saeRS mutants. In contrast to the in vitro data, there was no influence of saeRS on fnbA expression in the IE model, yet ex vivo fibronectin binding was reduced in saeRS mutants. Moreover, as opposed to the in vitro findings, sigB appeared to have a positive rather than a negative effect on saeRS expression within cardiac vegetations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom